# Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

> **NCT00003090** · PHASE2 · UNKNOWN · sponsor: **Cancer Biotherapy Research Group** · enrollment: 30 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin

## Key facts

- **NCT ID:** NCT00003090
- **Lead sponsor:** Cancer Biotherapy Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1996-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003090, "Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*